National Medical Products Administration

The official English portal of China’s National Medical Products Administration (NMPA) serves as the primary government gateway for regulatory affairs, policies, and news regarding pharmaceuticals, medical devices, and cosmetics in mainland China. Managed under the State Administration for Market Regulation (SAMR), the NMPA is tasked with formulating regulatory standards, overseeing product registrations, enforcing quality control, and ensuring public safety across healthcare supply chains. The website provides public access to major regulatory framework updates, legal texts, administrative provisions, and technical guidelines issued by the NMPA and its key affiliated bodies, including the Center for Drug Evaluation (CDE), the Center for Medical Device Evaluation (CMDE), and the Chinese Pharmacopoeia Commission. Key sections highlight policy interpretations for drug registration, medical device classification, clinical trial review processes, and international regulatory cooperation initiatives. Designed for global pharmaceutical companies, medical device manufacturers, legal experts, policy researchers, and academic institutions, this open resource provides authoritative primary data essential for studying Chinese administrative law, global healthcare compliance, regulatory affairs, and biopharmaceutical governance.